Royal Philips has set a goal to achieve an operating margin in the mid-teens by 2028. Bloomberg posted on X, highlighting the company's efforts to move past the expensive recall of its sleep apnea devices. The medical technology firm is focusing on improving its financial performance following the challenges posed by the recall. Philips is implementing strategies to enhance its operational efficiency and profitability over the coming years. The company is committed to restoring its reputation and financial stability as it navigates the aftermath of the recall incident.